Cigna
1,440 hedge funds and large institutions have $72.8B invested in Cigna in 2022 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 504 increasing their positions, 488 reducing their positions, and 75 closing their positions.
115% more first-time investments, than exits
New positions opened: 161 | Existing positions closed: 75
71% more funds holding in top 10
Funds holding in top 10: 31 → 53 (+22)
62% more call options, than puts
Call options by funds: $2.1B | Put options by funds: $1.3B
10% more capital invested
Capital invested by funds: $66.4B → $72.8B (+$6.44B)
5% more funds holding
Funds holding: 1,375 → 1,440 (+65)
3% more repeat investments, than reductions
Existing positions increased: 504 | Existing positions reduced: 488
0.04% more ownership
Funds ownership: 87.07% → 87.12% (+0.04%)
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$477M |
| 2 |
BlackRock
New York
|
-$345M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$246M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$193M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$183M |
CI Hedge Fund Activity: Q2 2022 in Review
1,440 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cigna (CI) for Q2 2022, worth a combined $72.8B — up 9.7% from $66.4B a quarter earlier.
Buyers outnumbered sellers: 161 funds opened new CI positions and 75 closed out — a net gain of 86 holders — while 504 added to existing stakes and 488 trimmed.
The largest buyer was Putnam Investments, adding an estimated $408M. The largest seller was T. Rowe Price Associates, cutting an estimated $477M.
- 1,440 institutional investors held Cigna (CI) as of Q2 2022, up from 1,375 in Q1 2022.
- Funds reported $72.8B of Cigna stock for Q2 2022, up 9.7% quarter-over-quarter.
- 161 funds opened new Cigna positions in Q2 2022 and 75 closed out, a net change of +86 holders.
- The largest Cigna buyer in Q2 2022 was Putnam Investments, an estimated $408M added.
- The largest Cigna seller in Q2 2022 was T. Rowe Price Associates, an estimated $477M sold.
Based on aggregated 13F filings for Q2 2022.